This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Asia Bio Partnering Forum

Early Bird Price ends in:

  • 00
  • 00
  • 00
  • 00
Marina Bay Sands Convention Center
April 24—25, 2024 | SingaporeApril 29—30, 2024 | Virtual

Novelna Inc.


Novelna is a biotech company that has built a technology platform leveraging market-disrupting approaches in the early disease detection. Our core technology is proteomics-based, testing is minimally invasive (urine and/or serum-based) and products are optimized for high early-stage performance. What sets us apart from our competitors is our platform approach, the focus on early-stage detection, a clear commercial focus on competitiveness, a well-defined route to early regulatory approval, as well as our ability to produce new diagnostics products tailored to specific demands.